Cargando…

Autoimmune encephalitis associated with COVID-19: A systematic review

INTRODUCTION: There are increasing reports of COVID-19 related neurological complications which may be due to direct viral invasion, or immune mediated inflammatory diseases such as autoimmune encephalitis and ADEM (acute demyelinating encephalomyelitis). In this study, a systematic review is presen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nabizadeh, Fardin, Balabandian, Mohammad, Sodeifian, Fatemeh, Rezaei, Negin, Rostami, Mohammad Reza, Naser Moghadasi, Abdorreza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983076/ https://www.ncbi.nlm.nih.gov/pubmed/35472834 http://dx.doi.org/10.1016/j.msard.2022.103795

Ejemplares similares

Psychological outcomes of the COVID-19 pandemic in patients with Parkinson’s disease: A systematic review
por: Nabizadeh, Fardin, et al.
Publicado: (2022)

Association of cognitive impairment and quality of life in patients with multiple sclerosis: A cross-sectional study
por: Nabizadeh, Fardin, et al.
Publicado: (2022)

Eculizumab in the treatment of neuromyelitis optica spectrum disorder
por: Nabizadeh, Fardin, et al.
Publicado: (2023)

Does statin use affect amyloid beta deposition and brain metabolism?
por: Nabizadeh, Fardin, et al.
Publicado: (2023)

COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity?
por: Naser Moghadasi, Abdorreza
Publicado: (2021)

Prevalence of COVID-19 infection in patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2021)

The Outcome of COVID-19 in Patients with a History of Taking Rituximab: A Narrative Review
por: Yarahmadi, Pourya, et al.
Publicado: (2021)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): A systematic review and meta-analysis
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2021)

The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2021)

Encephalopathy associated with COVID-19 in a patient with multiple sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

The first presentation of COVID-19 two hours after vaccination in a patient with multiple sclerosis: Can COVID vaccine provoke cytokine storm in a patient with asymptomatic COVID-19?
por: Ghadiri, Fereshteh, et al.
Publicado: (2021)

The big challenge for neurologists in treating patients with multiple sclerosis in the post-COVID-19 era
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

Initial clinical presentation of multiple sclerosis with concurrent COVID-19 infection: Case report and literature review
por: Ebadi, Zahra, et al.
Publicado: (2022)

Telemedicine as a strategic intervention for cognitive rehabilitation in MS patients during COVID-19
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

One Aspect of Coronavirus disease (COVID-19) Outbreak in Iran: High Anxiety among MS Patients
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

Use of Social Media Tools during COVID-19 Pandemic Among MS Fellowships and Patients
por: Mokhberdezfuli, Mahdieh, et al.
Publicado: (2023)

Evaluation of the Opinion of Patients With Multiple Sclerosis on the Outcomes of Catching COVID-19 and Its Effects on the MS Symptoms
por: Rezaeimanesh, Nasim, et al.
Publicado: (2020)

Knowledge regarding COVID-19 pandemic in patients with multiple sclerosis (MS): A report from Iran
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients
por: Haji Akhoundi, Fahimeh, et al.
Publicado: (2020)

Importance of T-cell response to COVID-19 vaccination in patients with multiple sclerosis treated by anti-CD20 therapies: New vaccines are required to be developed
por: Naser Moghadasi, Abdorreza
Publicado: (2021)

Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?
por: Paybast, Sepideh, et al.
Publicado: (2022)

Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study
por: Alirezaei, Mohammad, et al.
Publicado: (2021)

A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2021)

The study of COVID-19 infection following vaccination in patients with multiple sclerosis
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Recurrent isolated optic neuritis: A study on 22 patients
por: Arzani, Mahsa, et al.
Publicado: (2017)

The perspective of Iranian patients with multiple sclerosis on the third dose of COVID-19 vaccine
por: Ghadiri, Fereshteh, et al.
Publicado: (2022)

Association of COVID-19 and Acute Disseminated Encephalomyelitis (ADEM) in the absence of pulmonary involvement
por: Shahmirzaei, Shaghayegh, et al.
Publicado: (2021)

Watch out for neuromyelitis optica spectrum disorder onset or clinical relapse after COVID-19 vaccination: What neurologists need to know?
por: Paybast, Sepideh, et al.
Publicado: (2022)

The Possible Direct Correlation between Cognitive Impairment and Fear of Catching COVID-19 among Patients with Multiple Sclerosis
por: Saeedi, Roghayyeh, et al.
Publicado: (2021)

Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review
por: Ghadiri, Fereshteh, et al.
Publicado: (2023)

Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey
por: Fattahi, Mohammad Reza, et al.
Publicado: (2022)

Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Anti-N-methyl-D-aspartate receptor optic neuritis in a patient without history of encephalopathy
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2019)

Association of Limb-Girdle muscular dystrophy with multiple sclerosis: A case report
por: Arzani, Mahsa, et al.
Publicado: (2018)

Functional and structural lesion network mapping in neurological and psychiatric disorders: a systematic review
por: Nabizadeh, Fardin, et al.
Publicado: (2023)

Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

The Prevalence of Inflammatory Bowel Disease (IBD) in Patients with Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis
por: Nasirzadeh, Amirreza, et al.
Publicado: (2023)

Is Body Mass Index (BMI) Associated with Risk and Outcomes of COVID-19 in Iranian Multiple Sclerosis Patients?
por: Rezaeimanesh, Nasim, et al.
Publicado: (2023)

Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran
por: Sahraian, Mohammad Ali, et al.
Publicado: (2020)

Medical history risk factors in primary progressive multiple sclerosis: A case-control study
por: Maroufi, Hossein, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mg8qn6j8lrmd5ohnfjmkg9hs10